118 related articles for article (PubMed ID: 33937262)
1. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression.
Li X; Lin P; Tao Y; Jiang X; Li T; Wang Y; Wang C; Cao Y
Front Cell Dev Biol; 2021; 9():661122. PubMed ID: 33937262
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
5. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
6. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases.
Zhu S; Bennett S; Li Y; Liu M; Xu J
J Cell Physiol; 2022 Jan; 237(1):480-488. PubMed ID: 34550600
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET.
Shirasaki T; Yamagoe S; Shimakami T; Murai K; Imamura R; Ishii KA; Takayama H; Matsumoto Y; Tajima-Shirasaki N; Nagata N; Shimizu R; Yamanaka S; Abe A; Omura H; Kawaguchi K; Okada H; Yamashita T; Yoshikawa T; Takimoto K; Taharaguchi M; Takatsuka S; Miyazaki Y; Tamai T; Tanabe Y; Kurachi M; Yamamoto Y; Kaneko S; Matsumoto K; Takamura T; Honda M
Nat Commun; 2022 Jun; 13(1):3176. PubMed ID: 35676290
[TBL] [Abstract][Full Text] [Related]
9. The FOXM1/ATX signaling contributes to pancreatic cancer development.
Xie D; Yu S; Li L; Quan M; Gao Y
Am J Transl Res; 2020; 12(8):4478-4487. PubMed ID: 32913521
[TBL] [Abstract][Full Text] [Related]
10. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
11. HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma.
Zhao J; Wang Y; Wu X
Oncol Lett; 2018 Sep; 16(3):4013-4019. PubMed ID: 30128022
[TBL] [Abstract][Full Text] [Related]
12. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
13. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA PTTG3P/miR-132/212-3p/FoxM1 feedback loop facilitates tumorigenesis and metastasis of pancreatic cancer.
Liu W; Tang J; Zhang H; Kong F; Zhu H; Li P; Li Z; Kong X; Wang K
Cell Death Discov; 2020 Nov; 6(1):136. PubMed ID: 33298873
[TBL] [Abstract][Full Text] [Related]
15. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
17. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
[TBL] [Abstract][Full Text] [Related]
18. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
[TBL] [Abstract][Full Text] [Related]
19. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
